Hypertriglyceridemia is associated with insulin levels in adult cystic fibrosis patients

Journal of Cystic Fibrosis

Volumn 12, Issue 3, 2013, Pages 271-276

  Ishimo, Marie Claire ^a   Belson, Linda ^a,b   Ziai, Sophie ^a,b   Levy, Emile ^b,d   Berthiaume, Yves ^b,c   Coderre, Lise ^a,b   Rabasa Lhoret, Rémi ^a,b,c,e  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e Montreal Diabetes Research Centre   (Canada)

Author keywords

Body mass index; Cystic fibrosis; Dyslipidemia; Insulin secretion; Insulin sensitivity; Lung function; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE TOLERANCE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84876996736     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.08.012     Document Type: Article

References (28)

1. Dupuis A., Hamilton D., Cole D.E., Corey M. Cystic fibrosis birth rates in Canada: a decreasing trend since the onset of genetic testing. J Pediatr 2005 Sep, 147(3):312-315.
2. Canadian cystic fibrosis patient data registry report Available from: URL: http://www.cysticfibrosis.ca/assets/files/pdf/CPDR_ReportE.pdf. http://wwwcysticfibrosisca/assets/files/pdf/CPDR_ReportEpdf.
3. Leiter L.A., Fitchett D.H., Gilbert R.E., Gupta M., Mancini G.B., McFarlane P.A., et al. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol 2011 Mar, 27(2):e1-e33.
4. Costa M., Potvin S., Hammana I., Malet A., Berthiaume Y., Jeanneret A., et al. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 2007 Nov 30, 6(6):376-383.
5. Figueroa V., Milla C., Parks E.J., Schwarzenberg S.J., Moran A. Abnormal lipid concentrations in cystic fibrosis. Am J Clin Nutr 2002 Jun, 75(6):1005-1011.
6. Rhodes B., Nash E.F., Tullis E., Pencharz P.B., Brotherwood M., Dupuis A., et al. Prevalence of dyslipidemia in adults with cystic fibrosis. J Cyst Fibros 2010 Jan, 9(1):24-28.
7. Howard B.V., Cowan L.D., Go O., Welty T.K., Robbins D.C., Lee E.T. For the strong heart study investigators. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. Diabetes Care 1998, 21:1258-1265.
8. Genest J., McPherson R., Frohlich J., Anderson T., Campbell N., Carpentier A., et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009 Oct, 25(10):567-579.
9. Howard B.V., Robbins D.C., Sievers M.L., Lee E.T., Rhoades D., Devereux R.B., et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler Thromb Vasc Biol 2000 Mar, 20(3):830-835.
10. Hanley A.J., Williams K., Stern M.P., Haffner S.M. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002 Jul, 25(7):1177-1184.
11. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2009 Jan;32 Suppl 1:S62-S67.
12. Ziai S., Belson L., Hammana I., Berthiaume Y., Rabasa-Lhoret R. Validation of insulin secretion indices in cystic fibrosis. J Cyst Fibros 2011 Mar, 10(2):145.
13. Stumvoll M., Van H.T., Fritsche A., Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001 Apr, 24(4):796-797.
14. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 Jun, 18(6):499-502.
15. Stampfer M.J., Krauss R.M., Ma J., Blanche P.J., Holl L.G., Sacks F.M., et al. A prospective study of triglyceride level, low-density lipoprotein, particle diameter, and risk of myocardial infarction. JAMA 1996, 276:882-888.
16. Lemieux I., Lamarche B., Couillard C., Pascot A., Cantin B., Bergeron J., et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 2001 Dec 10, 161(22):2685-2692.
17. Labombarda F., Pellissier A., Ellafi M., Creveuil C., Ribault V., Laurans M., et al. Myocardial strain assessment in cystic fibrosis. J Am Soc Echocardiogr 2011 Sep, 24(9):1037-1045.
18. Chen H., Liu L.L., Ye L.L., McGuckin C., Tamowski S., Scowen P., et al. Targeted inactivation of cystic fibrosis transmembrane conductance regulator chloride channel gene prevents ischemic preconditioning in isolated mouse heart. Circulation 2004 Aug 10, 110(6):700-704.
19. Perrin F.M., Serino W. Ischaemic heart disease-a new issue in cystic fibrosis?. J R Soc Med 2010 Jul, 103(Suppl. 1):S44-S48.
20. Georgiopoulou V.V., Denker A., Bishop K.L., Brown J.M., Hirsh B., Wolfenden L., et al. Metabolic abnormalities in adults with cystic fibrosis. Respirology 2010 Jul, 15(5):823-829.
21. Street M.E., Spaggiari C., Ziveri M.A., Rossi M., Volta C., Viani I., et al. Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype. J Endocrinol Invest 2012 Mar, 35(3):246-253.
22. Anzeneder L., Kircher F., Feghelm N., Fischer R., Seissler J. Kinetics of insulin secretion and glucose intolerance in adult patients with cystic fibrosis. Horm Metab Res 2011 May, 43(5):355-360.
23. Tobey T.A., Greenfield M., Kraemer F., Reaven G.M. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man. Metabolism 1981, 30:165-171.
24. Rigalleau V., Beylot M., Pachiaudi C., Guillot C., Deleris G., Gin H. Mechanisms of glucose intolerance during triglyceride infusion. Am J Physiol 1998 Oct, 275:E641-E648.
25. Karamanos B.G., Thanopoulou A.C., Roussi-Penesi D.P. Maximal post-prandial triglyceride increase reflects post-prandial hypertriglyceridaemia and is associated with the insulin resistance syndrome. Diabet Med 2001 Jan, 18(1):32-39.
26. Maheux P., Azhar S., Kern P.A., Chen Y.-D.I., Reaven G.M. Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia 1997, 40:850-858.
27. Raz I., Eldor R., Cernea S., Shafrir E. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab Res Rev 2005 Jan, 21(1):3-14.
28. Moran A., Basu R., Milla C., Jensen M.D. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance. Metabolism 2004 Nov, 53(11):1467-1472.